Table 4.
Attribute | Class 1 |
Class 2 |
Class 3 |
|||
---|---|---|---|---|---|---|
ß | SEa | ß | SE | ß | SE | |
Vaccine effectiveness | ||||||
60% | 0.202*** | 0.042 | 0.736*** | 0.212 | 2.366*** | 0.231 |
85% | 0.505*** | 0.049 | 1.806*** | 0.167 | 4.435*** | 0.338 |
Vaccine related side-effects | ||||||
10/100,000 | 0.170*** | 0.039 | 3.134*** | 0.105 | 0.790*** | 0.168 |
1/100,000 | 0.366*** | 0.043 | 6.510*** | 0.532 | 0.935*** | 0.204 |
Access to vaccine | ||||||
Free and compulsory | 0.043 | 0.037 | −1.007*** | 0.190 | 0.434** | 0.180 |
Chargeable and voluntary | 0.000*** | 0.039 | −2.017*** | 0.164 | 0.145 | 0.176 |
Number of doses | ||||||
≥2 doses | −0.037 | 0.027 | −0.902*** | 0.108 | 0.218* | 0.115 |
Vaccination sites | ||||||
Second level | −0.072** | 0.037 | 0.493** | 0.203 | 0.114 | 0.180 |
Third level | 0.025 | 0.036 | 0.844*** | 0.163 | 0.173 | 0.163 |
Duration of vaccine protection | ||||||
One year | 0.187*** | 0.037 | −0.412*** | 0.149 | 0.102 | 0.151 |
More than two years | 0.309*** | 0.036 | 0.151 | 0.215 | 0.606*** | 0.196 |
Acquaintances vaccinated | ||||||
60% | 0.221*** | 0.036 | 0.798*** | 0.188 | −0.161 | 0.180 |
90% | 0.405*** | 0.037 | 0.522*** | 0.168 | −0.006 | 0.163 |
Class probability model | ||||||
Age | 0.467*** | 0.119 | 0.350** | 0.135 | – | – |
Education | −0.257*** | 0.093 | 0.109 | 0.105 | – | – |
Region | 0.183** | 0.090 | 0.083 | 0.098 | – | – |
Average monthly household income | −0.375*** | 0.086 | −0.109 | 0.094 | – | – |
Trust in vaccines | −0.156 | 0.104 | −0.558*** | 0.125 | – | – |
Risk of infection | −0.094 | 0.088 | −0.228** | 0.103 | – | – |
Constant | 1.707*** | 0.353 | 0.242 | 0.485 | – | – |
Class probability | ||||||
Average | 0.548 | 0.232 | 0.219 | |||
Model fit | ||||||
Observations = 30128 | ||||||
Respondents = 1883 | ||||||
AIC | 16334.25 | |||||
BIC | 16766.54 |
SE standard errors.
Statistically significant at the 1%.
At 5%.
At 10% level.